Form 4: Dermata Therapeutics CEO Receives Stock Grant
Insider Transaction (Form 4)
Gerald T Proehl, PRESIDENT, CHAIRMAN, CEO, a Director and 10% owner of Dermata Therapeutics, Inc., reported multiple transactions in common stock on August 16, 2025.
Summary
- Grant/award: acquired 170,068 Common Stock on August 16, 2026; holds 292,631 after (Indirect).
- Grant/award: acquired 1,360,544 Series E Warrant (Right to Buy) on August 16, 2026; holds 1,360,544 after (Indirect).
- Grant/award: acquired 1,360,544 Series F Warrant (Right to Buy) on August 16, 2026; holds 1,360,544 after (Indirect).
- Grant/award: acquired 170,068 Series E Warrant (Right to Buy) on August 16, 2026; holds 170,068 after (Indirect).
- Grant/award: acquired 170,068 Series F Warrant (Right to Buy) on August 16, 2026; holds 170,068 after (Indirect).
- Grant/award: acquired 1,360,544 Pre-Funded Warrant (Right to Buy) on August 16, 2026; holds 1,360,544 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Gerald T Proehl — Director, Officer (PRESIDENT, CHAIRMAN, CEO), 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-16 | Grant/award | Common Stock | 170,068 | — | — | 292,631 |
| 2026-08-16 | Grant/award | Series E Warrant (Right to Buy) | 1,360,544 | — | — | 1,360,544 |
| 2026-08-16 | Grant/award | Series F Warrant (Right to Buy) | 1,360,544 | — | — | 1,360,544 |
| 2026-08-16 | Grant/award | Series E Warrant (Right to Buy) | 170,068 | — | — | 170,068 |
| 2026-08-16 | Grant/award | Series F Warrant (Right to Buy) | 170,068 | — | — | 170,068 |
| 2026-08-16 | Grant/award | Pre-Funded Warrant (Right to Buy) | 1,360,544 | — | — | 1,360,544 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-16 | Grant/award (170,068 shares) |
| 2026-08-16 | Grant/award (1,360,544 shares) |
| 2026-08-16 | Grant/award (1,360,544 shares) |
| 2026-08-16 | Grant/award (170,068 shares) |
| 2026-08-16 | Grant/award (170,068 shares) |
| 2026-08-16 | Grant/award (1,360,544 shares) |
Keywords
insider transaction, Form 4, DRMA, Dermata Therapeutics, Inc., neutral, Gerald T Proehl
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.